Abstract:Abstract Background Genome-wide association studies have identified genetic variants associated with the risk of brain-related diseases, such as neurological and psychiatric disorders, while the causal variants and the specific vulnerable cell types are often needed to be studied. Many disease-associated genes are expressed in multiple cell types of human brains, while the pathologic variants affect primarily specific cell types. We hypothesize a model in which what determines the manifestation of a disease in a cell type is the presence of disease module comprised of disease-associated genes, instead of individual genes. Therefore, it is essential to identify the presence/absence of disease gene modules in cells. Methods To characterize the cell type-specificity of brain-related diseases, we construct human brain cell type-specific gene interaction networks integrating human brain nucleus gene expression data with a referenced tissue-specific gene interaction network. Then from the cell type-specific gene interaction networks, we identify significant cell type-specific disease gene modules by performing statistical tests. Results Between neurons and glia cells, the constructed cell type-specific gene networks and their gene functions are distinct. Then we identify cell type-specific disease gene modules associated with autism spectrum disorder and find that different gene modules are formed and distinct gene functions may be dysregulated in different cells. We also study the similarity and dissimilarity in cell type-specific disease gene modules among autism spectrum disorder, schizophrenia and bipolar disorder. The functions of neurons-specific disease gene modules are associated with synapse for all three diseases, while those in glia cells are different. To facilitate the use of our method, we develop an R package, CtsDGM, for the identification of cell type-specific disease gene modules. Conclusions The results support our hypothesis that a disease manifests itself in a cell type through forming a statistically significant disease gene module. The identification of cell type-specific disease gene modules can promote the development of more targeted biomarkers and treatments for the disease. Our method can be applied for depicting the cell type heterogeneity of a given disease, and also for studying the similarity and dissimilarity between different disorders, providing new insights into the molecular mechanisms underlying the pathogenesis and progression of diseases.

Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders.

Cell Type Specific Analysis of Human Brain Transcriptome Data to Predict Alterations in Cellular Composition.

An analytical method for the identification of cell type-specific disease gene modules

Cell Type-Specific Gene Network-Based Analysis Depicts the Heterogeneity of Autism Spectrum Disorder

High-throughput single-cell functional elucidation of neurodevelopmental disease-associated genes reveals convergent mechanisms altering neuronal differentiation

Cell type-specific predictive models for prioritizing genes and gene sets associated with autism spectrum disorder

Cell Type Specific Analysis Of Human Transcriptome Data

Human Brain Cell Type-Specific Gene Co-Expression Associated with Autism Spectrum Disorder

Mapping the Cellular Etiology of Schizophrenia and Diverse Brain Phenotypes

Gene Screening for Autism Based on Cell-type-specific Predictive Models.

Shared and Cell-Type-Specific Gene Expression Patterns Associated with Autism Revealed by Integrative Regularized Non-Negative Matrix Factorization

Gene Module Analysis Reveals Cell-Type Specificity and Potential Target Genes in Autism’s Pathogenesis

Brain cell-type shifts in Alzheimer's disease, autism, and schizophrenia interrogated using methylomics and genetics

Molecular cascades and cell type–specific signatures in ASD revealed by single-cell genomics

A scalable, high-throughput neural development platform identifies shared impact of ASD genes on cell fate and differentiation

Prioritizing Genes Associated with Brain Disorders by Leveraging Enhancer-Promoter Interactions in Diverse Neural Cells and Tissues

Proximity analysis of native proteomes reveals phenotypic modifiers in a mouse model of autism and related neurodevelopmental conditions

cis-Regulatory Chromatin Contacts in Neural Cells Reveal Contributions of Genetic Variants to Complex Neurological Disorders

Cell Type-Specific Predictive Models Perform Prioritization of Genes and Gene Sets Associated With Autism

Neuronal and Glial 3D Chromatin Architecture Informs the Cellular Etiology of Brain Disorders

Single-cell genomics identifies cell type–specific molecular changes in autism